Divis Laboratories Ltd | DIVI - Ebitda

Stock Price
6,241.00
Daily Change
-52.50 -0.83%
Monthly
3.05%
Yearly
8.99%
Q1 Forecast
6,171.47

Divis Laboratories Ltd reported INR8.9B in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Aurobindo Pharma INR 17.73B 952.4M Dec/2025
Avita Medical AUD -21.9M 12.04M Jun/2025
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Divis Laboratories Ltd INR 8.9B 20M Dec/2025
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
IQVIA Holdings USD 1.05B 97M Dec/2025
Lupin INR 23.09B 318.5M Dec/2025
Moderna USD -790M 582M Dec/2025
Organon & Co USD 383M 135M Dec/2025
Revvity USD 248.91M 48.52M Dec/2025
Tectonic Therapeutic USD -13.48M 5.73M Dec/2024
Tilray USD 8.36M 1.82M Sep/2025
Viatris USD 1.15B 75.8M Sep/2025
Xeris Pharmaceuticals USD 17.42M 8.83M Sep/2025